Replimune Group, Inc. - COMMON STOCK (REPL)

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COMMON STOCK
Shares outstanding
78,365,632
Total 13F shares
34,863,218
Share change
-254,852
Total reported value
$1,338,855,937
Put/Call ratio
461%
Price per share
$38.42
Number of holders
109
Value change
-$5,476,278
Number of buys
52
Number of sells
48

Institutional Holders of Replimune Group, Inc. - COMMON STOCK (REPL) as of Q2 2021

As of 30 Jun 2021, Replimune Group, Inc. - COMMON STOCK (REPL) was held by 109 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,863,218 shares. The largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, Omega Fund Management, LLC, Redmile Group, LLC, BlackRock Inc., STATE STREET CORP, Ensign Peak Advisors, Inc, VANGUARD GROUP INC, FMR LLC, LOOMIS SAYLES & CO L P, and BVF INC/IL. This page lists 109 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.